Therapeutic antibodies have revolutionized biopharmaceutical drug development, offering targeted treatments for a range of diseases, from autoimmune disorders to oncology. However, immunogenicity remains a critical hurdle, as the formation of anti-drug antibodies (ADAs) can impact drug efficacy, ... Read more
Therapeutic antibodies have transformed modern biopharmaceuticals, providing targeted and highly specific treatments for a range of diseases, including oncology, autoimmune disorders, and infectious diseases. However, immunogenicity concerns, particularly the development of anti-drug antibodies ... Read more
Advancing scientific discovery with validated research tools For researchers in immunology, inflammation, and rare disease research, choosing the best immunoassays and cell-based assays is critical for generating reliable, high-impact data. Our assays have been now featured in 600+ peer-reviewed ... Read more
February 22 is World Encephalitis Day, and we are proud to join the encephalitis community and Encephalitis International to raise global awareness of encephalitis and the importance of early diagnosis. Join Wieslab and Svar Life Science by wearing red and participating in the #Red4WED campaign to ... Read more
